KROS - Keros Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KROS is currently covered by 9 analysts with an average price target of $32.66. This is a potential upside of $21.19 (184.74%) from yesterday's end of day stock price of $11.47.

Keros Therapeutics 's activity chart (see below) currently has 24 price targets and 53 ratings on display. The stock rating distribution of KROS is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30.33% with an average time for these price targets to be met of 46.3 days.

Highest price target for KROS is $43, Lowest price target is $15, average price target is $23.5.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 27-Feb-2025. First documented stock forecast 04-May-2020.

Currently out of the existing stock ratings of KROS, 32 are a BUY (88.89%), 4 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$40

$28.62 (251.49%)

$47

14 days ago
(27-Feb-2025)

1/12 (8.33%)

$29.06 (265.63%)

113

Buy

$26

$14.62 (128.47%)

$111

14 days ago
(27-Feb-2025)

1/3 (33.33%)

$15.06 (137.66%)

74

Buy

$15

$3.62 (31.81%)

$105

1 months 24 days ago
(17-Jan-2025)

5/12 (41.67%)

$4.14 (38.12%)

43

Hold

1 months 24 days ago
(17-Jan-2025)

0/1 (0%)

$41.46 (76.02%)

Buy

$23

$11.62 (102.11%)

$63

1 months 25 days ago
(16-Jan-2025)

0/7 (0%)

$12.48 (118.63%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KROS (Keros Therapeutics ) average time for price targets to be met?

On average it took 46.3 days on average for the stock forecasts to be realized with a an average price target met ratio 30.33

Which analyst has the current highest performing score on KROS (Keros Therapeutics ) with a proven track record?

JOSEPH CATANZARO

Which analyst has the most public recommendations on KROS (Keros Therapeutics )?

Joseph Catanzaro works at PIPER SANDLER and has 9 price targets and 7 ratings on KROS

Which analyst is the currently most bullish on KROS (Keros Therapeutics )?

Srikripa Devarakonda with highest potential upside - $31.62

Which analyst is the currently most reserved on KROS (Keros Therapeutics )?

Julian Harrison with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?